Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)

John Nikitas; Ethan Lam; Kiara Adame Booker; Wolfgang P. Fendler; Matthias Eiber; Boris Hadaschik; Ken Herrmann; Nader Hirmas; Helena Lanzafame; Martin Stuschke; Johannes Czernin; Michael L. Steinberg; Nicholas G. Nickols; Amar U. Kishan; Jeremie Calais

doi:10.2967/jnumed.123.267004

Research ArticleBRIEF COMMUNICATION

Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)

John Nikitas, Ethan Lam, Kiara Adame Booker, Wolfgang P. Fendler, Matthias Eiber, Boris Hadaschik, Ken Herrmann, Nader Hirmas, Helena Lanzafame, Martin Stuschke, Johannes Czernin, Michael L. Steinberg, Nicholas G. Nickols, Amar U. Kishan and Jeremie Calais

Journal of Nuclear Medicine July 2024, 65 (7) 1076-1079; DOI: https://doi.org/10.2967/jnumed.123.267004

John Nikitas

1Department of Radiation Oncology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ethan Lam

2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kiara Adame Booker

2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wolfgang P. Fendler

3Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Eiber

2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Boris Hadaschik

4Department of Urology, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ken Herrmann

3Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nader Hirmas

3Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helena Lanzafame

3Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin Stuschke

5Department of Radiotherapy, University Hospital Essen, University of Duisburg–Essen, Essen, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Czernin

2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael L. Steinberg

1Department of Radiation Oncology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicholas G. Nickols

1Department of Radiation Oncology, UCLA, Los Angeles, California;

6Radiation Oncology Service, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Amar U. Kishan

1Department of Radiation Oncology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeremie Calais

2Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue 7

July 1, 2024

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)

Journal of Nuclear Medicine Jul 2024, 65 (7) 1076-1079; DOI: 10.2967/jnumed.123.267004

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)

Journal of Nuclear Medicine Jul 2024, 65 (7) 1076-1079; DOI: 10.2967/jnumed.123.267004

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

PET
prostate cancer
prostate-specific membrane antigen
radiation therapy
randomized clinical trial

Main menu

User menu

Search

Randomized Trial of Prostate-Specific Membrane Antigen PET/CT Before Definitive Radiotherapy for Unfavorable Intermediate- and High-Risk Prostate Cancer (PSMA-dRT Trial)

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords